Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab

Figure 3

Lung imaging results during the course of the disease. Chest CT imaging is shown for the time between October 2016 and October 2017. For the October 2016 CT image, the lesion is indicated by an arrow.